var data={"title":"Chlorhexidine gluconate (topical): Pediatric drug information","body":"<div id=\"topicContent\" class=\"utdArticleSection utdStyle\"><div id=\"drugTitle\">Chlorhexidine gluconate (topical): Pediatric drug information</div><div id=\"lexiTitleImg\"></div><div class=\"clear\"></div><div id=\"lcoSearchClickUrl\"><a href=\"http://online.lexi.com/lco/action/api/find/globalid/319099?utd=1\" target=\"_blank\">Access Lexicomp Online here.</a></div><div id=\"drugCopy\">Copyright 1978-2018 Lexicomp, Inc. All rights reserved.</div><div id=\"topicText\">(For additional information <a href=\"topic.htm?path=chlorhexidine-gluconate-topical-drug-information\" class=\"drug drug_general\">see &quot;Chlorhexidine gluconate (topical): Drug information&quot;</a> and <a href=\"topic.htm?path=chlorhexidine-gluconate-topical-patient-drug-information\" class=\"drug drug_patient\">see &quot;Chlorhexidine gluconate (topical): Patient drug information&quot;</a>)<br></br>For abbreviations and symbols that may be used in Lexicomp (<a href=\"image.htm?imageKey=DRUG%2F57469\" class=\"graphic graphic_table\">show table</a>)<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F50509982\" class=\"list ubnlist drugH1Div drugBrandNames\"><span class=\"drugH1\">Brand Names: US</span>\n    <ul>\n      <li>Antiseptic Skin Cleanser [OTC];</li>\n      <li>Betasept Surgical Scrub [OTC];</li>\n      <li>ChloraPrep One Step [OTC] [DSC];</li>\n      <li>Dyna-Hex 2 [OTC];</li>\n      <li>Hibiclens [OTC];</li>\n      <li>Hibistat [OTC] [DSC];</li>\n      <li>Tegaderm CHG Dressing [OTC]</li></ul></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F50510537\" class=\"list_set htclist drugH1Div drugBrandNames\"><span class=\"drugH1\">Therapeutic Category</span>\n    <ul>\n      <li>\n        <span class=\"list-set-name\">Antibiotic, Oral Rinse</span>;</li>\n      <li>\n        <span class=\"list-set-name\">Antibiotic, Topical</span></li></ul></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F50713394\" class=\"block don drugH1Div\"><span class=\"drugH1\">Dosing: Neonatal</span>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>Skin cleanser, procedural (eg, phleobotomy, central line placement [PICC, UAC], line maintenance care): Note:</b> Guidelines for pediatric patients and adults recommend using a &gt;0.5% chlorhexidine preparation in alcohol; however, no recommendations are provided for neonates and infants &lt;2 months (IDSA [O&rsquo;Grady 2011]). NICU specific recommendations suggest no preferred agent, but advise against using tincture of iodine (AAP [Polin 2012]); most neonatal studies have used a 2% chlorhexidine and alcohol preparation (Chapman 2013; Garland 2009; O&rsquo;Connor 2016); a few studies have used a 0.5% chlorhexidine concentration (Garland 1995; Garland 1996). It is recommended to use chlorhexidine-containing products with care in this population due to potential risk of dermal irritation or chemical burns.</p>\n    <p style=\"text-indent:0em;margin-left:4em;\">Premature or term neonates with body weight &gt;1.5 kg and PNA &gt;7 days: Limited data available: Topical: Cleanse site with chlorhexidine product for ~30 seconds, allow to dry (~30 to 60 seconds) prior to line insertion, dressing application or lab draw (Chapman 2013; Garland 1995; Garland 2009; O&rsquo;Connor 2016). <b>Note:</b> Minimal age and weight variable; use has been evaluated in ELBW neonates with GA as young as 24 weeks and birth weight as low as 630 g (Chapman 2013); some studies suggest, however, an increased risk of skin irritation and burns with decreased maturity and bodyweight (AAP [Polin 2010]; Garland 1996; Garland 2009; Tamma 2010); risk versus benefit must be weighed prior to use in neonates.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F50713395\" class=\"block dos drugH1Div\"><span class=\"drugH1\">Dosing: Usual</span><p>(For additional information <a href=\"topic.htm?path=chlorhexidine-gluconate-topical-drug-information\" class=\"drug drug_general\">see &quot;Chlorhexidine gluconate (topical): Drug information&quot;</a>)</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Pediatric: <b>Skin cleanser for preoperative skin preparation, skin wound and general skin cleanser for patients:</b> Topical:</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Infants &lt;2 months: <b>Note:</b> It is recommended to use with care in this population due to potential risk of dermal irritation or chemical burns. Expert suggestions are variable depending upon site and clinical scenario. Not all products may be appropriate for use in this population; refer to product specific labeling. Some experience in neonatal patients applicable to this patient population (Garland 2009; Tamma 2010).</p>\n    <p style=\"text-indent:-2em;margin-left:6em;\">\n      <i>Preoperative skin preparation: </i>Solution: Apply liberally to surgical site and swab for at least 2 minutes. Dry with sterile towel. Repeat procedure (swab for additional 2 minutes and dry with sterile towel).</p>\n    <p style=\"text-indent:-2em;margin-left:6em;\">\n      <i>Wound care and general skin cleansing</i>: Rinse area with water, then apply the minimum amount of chlorhexidine necessary to cover skin or wound area and wash gently. Rinse again thoroughly.</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Infants &ge;2 months, Children, and Adolescents: Topical solution:</p>\n    <p style=\"text-indent:-2em;margin-left:6em;\">\n      <i>Preoperative skin preparation: </i>Solution: Apply liberally to surgical site and swab for at least 2 minutes. Dry with sterile towel. Repeat procedure (swab for additional 2 minutes and dry with sterile towel).</p>\n    <p style=\"text-indent:-2em;margin-left:6em;\">\n      <i>Wound care and general skin cleansing</i>: Rinse area with water, then apply the minimum amount of chlorhexidine necessary to cover skin or wound area and wash gently. Rinse again thoroughly.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Adult: <b>Skin cleanser for preoperative skin preparation, skin wound and general skin cleanser for patients; surgical scrub and antiseptic hand rinse for healthcare personnel:</b> Topical:</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">\n      <i>Surgical scrub:</i> Wet hands and arms with water; scrub hands and forearms with ~5 mL or chlorhexidine sponge for 3 minutes paying close attention to nails, cuticles, and interdigital spaces, and rinse thoroughly; wash with another ~5 mL for an additional 3 minutes, rinse, and dry thoroughly.</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">\n      <i>Health care personnel hand antiseptic:</i> Wet hand with water and wash with ~5 mL for 15 seconds; rinse thoroughly with water and dry.</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">\n      <i>Preoperative skin preparation:</i> Solution: Apply liberally to surgical site and swab for at least 2 minutes. Dry with sterile towel. Repeat procedure (swab for additional 2 minutes and dry with sterile towel).</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">\n      <i>Preparation of skin prior to an injection: </i>Swab: Apply swab to procedure site for 15 seconds; allow to air dry for 30 seconds (do not blot or wipe dry). <b>Note:</b> Maximum treatment area for 1 swab is ~2.5 inches x 2.5 inches.</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">\n      <i>Wound care and general skin cleansing</i>: Rinse area with water, then apply minimum amount necessary to cover skin or wound area and wash gently. Rinse again thoroughly.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>Dosing adjustment in renal impairment: </b>There are no dosage adjustments provided in the manufacturer's labeling.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>Dosing adjustment in hepatic impairment: </b>There are no dosage adjustments provided in the manufacturer's labeling.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F50828729\" class=\"block foc drugH1Div\"><span class=\"drugH1\">Dosage Forms</span>\n    <p style=\"text-indent:0em;text-align:justify;display:inline\">Excipient information presented when available (limited, particularly for generics); consult specific product labeling.  [DSC] = Discontinued product</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Liquid, External: </p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Betasept Surgical Scrub: 4% (118 mL, 237 mL, 473 mL, 946 mL, 3780 mL [DSC])</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Hibiclens: 4% (15 mL, 118 mL, 236 mL, 473 mL, 946 mL, 3790 mL) [contains fd&amp;c red #40, isopropyl alcohol]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Generic: 2% (118 mL); 4% (118 mL, 237 mL, 473 mL, 946 mL, 3800 mL)</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Miscellaneous, External: </p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Hibistat: 0.5% (50 ea [DSC]) [contains isopropyl alcohol]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Tegaderm CHG Dressing: (Dressing) (1 ea)</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Pad, External: </p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Generic: 2% (2 ea, 6 ea)</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Solution, External: </p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Antiseptic Skin Cleanser: 4% (118 mL, 237 mL) [dye free; contains isopropyl alcohol]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">ChloraPrep One Step: 2% (3 mL [DSC], 10.5 mL [DSC]) [latex free]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Dyna-Hex 2: 2% (473 mL) [contains isopropyl alcohol]</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F50509985\" class=\"block geq drugH1Div\"><span class=\"drugH1\">Generic Availability (US)</span>\n    <p style=\"text-indent:0em;display:inline\">May be product dependent</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F50510540\" class=\"block adm drugH1Div\"><span class=\"drugH1\">Administration</span>\n    <p style=\"text-indent:0em;display:inline\">Topical: Keep out of eyes, ears, and mouth. Do not routinely apply to wounds which involve more than superficial layers of skin. Avoid contact with meninges (ie, do not use on lumbar puncture sites). Solutions may be flammable (may contain alcohol); consult specific product labeling to determine if product may be used with electrocautery procedures; if product can be used near an ignition source (eg, cautery, laser), avoid exposure to open flame and/or ignition source until completely dry; avoid application to hairy areas which may significantly delay drying time. When using the ChloraPrep applicator, do not touch sponge. Hold applicator sponge down and pinch wings of applicator once to activate ampul and release antiseptic.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F50510015\" class=\"block sts drugH1Div\"><span class=\"drugH1\">Storage/Stability</span>\n    <p style=\"text-indent:0em;display:inline\">Store at room temperature. Alcohol-containing topical products are flammable; keep away from flames or fire.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F50510538\" class=\"block use drugH1Div\"><span class=\"drugH1\">Use</span>\n    <p style=\"text-indent:0em;display:inline\">Topical: Skin cleanser for preoperative skin preparation, prior to injection; skin wound and general skin cleanser for patients (FDA approved in pediatric patients [age not specified] and adults); surgical scrub and antiseptic hand rinse for health care personnel (FDA approved in adults). <b>Note:</b> Indications vary by product; refer to specific product labeling for details.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F50510005\" class=\"block arm drugH1Div\"><span class=\"drugH1\">Adverse Reactions</span>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Dermatologic: Allergic sensitization, erythema, hypersensitivity reaction, rough skin, xeroderma</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Rare but important or life-threatening: Anaphylaxis (Health Canada May 2016), dyspnea, facial edema, nasal congestion</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F50510000\" class=\"block coi drugH1Div\"><span class=\"drugH1\">Contraindications</span>\n    <p style=\"text-indent:0em;display:inline\">Hypersensitivity to chlorhexidine or any component of the formulation</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F50510001\" class=\"block war drugH1Div\"><span class=\"drugH1\">Warnings/Precautions</span>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>\n        <i>Concerns related to adverse effects:</i></b></p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Hypersensitivity reactions: Serious allergic reactions, including anaphylaxis, have been reported.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>\n        <i>Dosage form specific issues:</i></b></p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Topical: For topical use only. Keep out of eyes, ears, and the mouth; if contact occurs, rinse with cold water immediately; permanent eye injury may result if agent enters and remains in the eye. Deafness has been reported following instillation in the middle ear through perforated ear drums. Avoid applying to wounds that involve more than the superficial skin layers. Avoid repeated use as general skin cleansing of large surfaces (unless necessary for condition). Not for preoperative preparation of face or head; avoid contact with meninges (do not use on lumbar puncture sites). Avoid applying to genital areas; generalized allergic reactions, irritation, and sensitivity have been reported. Solutions may be flammable (products may contain alcohol); avoid exposure to open flame and/or ignition source (eg, electrocautery) until completely dry; avoid application to hairy areas which may significantly delay drying time. Use with caution in children &lt;2 months of age due to potential for increased absorption, and risk of irritation or chemical burns. May cause staining of fabrics (brown stain) due to a chemical reaction between chlorhexidine gluconate bound to fabric and chlorine (if sufficient chlorine is present from certain laundry detergents used during laundering process).</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>\n        <i>Other warnings/precautions:</i></b></p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Appropriate use: Topical: When used as a topical antiseptic, improper use may lead to product contamination. Although infrequent, product contamination has been associated with reports of localized and systemic infections. To reduce the risk of infection, ensure antiseptic products are used according to the labeled instructions; avoid diluting products after opening; and apply single-use containers only one time to one patient and discard any unused solution (FDA Drug Safety Communication, 2013).</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F50713392\" class=\"block add-pediatric-warn-info drugH1Div\"><span class=\"drugH1\">Warnings: Additional Pediatric Considerations</span>\n    <p style=\"text-indent:0em;display:inline\">Although topical chlorhexidine is widely used in many NICUs as a skin cleanser prior to procedures (eg, central venous line placement/care) (Tamma 2010), data is lacking to support use in premature infants. Manufacturer's labeling recommends using with caution in premature neonates and infants &lt;2 months of age as chlorhexidine-containing products may cause irritation or chemical burns. A survey of US NICU chlorhexidine use reports dermal burns occurring more frequently in neonates with birth weight &lt;1,500 g (Tamma 2010). If used for neonatal dermal site cleansing, some suggest using sterile water or normal saline to remove excess disinfectant after procedures may help avoid chemical burns (Eichenwald 2017; Nuntnarumit 2013). Several studies have noted detectable serum concentrations in neonates after chlorhexidine exposure; no correlation between serum concentration and GA, birth weight, or PNA was identified; the clinical significance is undetermined (Chapman 2013; Garland 2009).</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F50510010\" class=\"block cyt drugH1Div\"><span class=\"drugH1\">Metabolism/Transport Effects</span>\n    <p style=\"text-indent:0em;display:inline\">None known.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F50510007\" class=\"block dri drugH1Div\"><span class=\"drugH1\">Drug Interactions</span>\n    <br/><br/><div id=\"lexiInteractAddInfo\" class=\"lexi\">(For additional information: <a href=\"https://www.uptodate.com/drug-interactions/?search=&amp;topicId=115977&amp;source=responsive_topic\" class=\"dip\" target=\"_blank\">Launch drug interactions program</a>)</div><div id=\"lexiInteractImgB\" class=\"lexi\"><img src=\"/images/lexiComp/Lexicomp_2012_71x17.gif\" width=\"71\" height=\"17\" border=\"0\"/></div><div class=\"clear\"></div><p style=\"text-indent:0em;display:inline\">There are no known significant interactions.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F50509997\" class=\"block pri drugH1Div\"><span class=\"drugH1\">Pregnancy Implications</span>\n    <p style=\"text-indent:0em;display:inline\">No reports of adverse effects in newborns have been reported, even though chlorhexidine is commonly used during labor and in the neonate. Moreover, only very small amounts of disinfectant reach the maternal circulation and the fetus.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F50713396\" class=\"block mop drugH1Div\"><span class=\"drugH1\">Monitoring Parameters</span>\n    <p style=\"text-indent:0em;display:inline\">Topical: Monitor for redness/skin irritation especially in infants &lt;2 months</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F50510016\" class=\"block pha drugH1Div\"><span class=\"drugH1\">Mechanism of Action</span>\n    <p style=\"text-indent:0em;display:inline\">Chlorhexidine has activity against gram-positive and gram-negative organisms, facultative anaerobes, aerobes, and yeast; it is both bacteriostatic and bactericidal, depending on its concentration. The bactericidal effect of chlorhexidine is a result of the binding of this cationic molecule to negatively charged bacterial cell walls and extramicrobial complexes. At low concentrations, this causes an alteration of bacterial cell osmotic equilibrium and leakage of potassium and phosphorous resulting in a bacteriostatic effect. At high concentrations of chlorhexidine, the cytoplasmic contents of the bacterial cell precipitate and result in cell death.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F50510017\" class=\"block phk drugH1Div\"><span class=\"drugH1\">Pharmacodynamics/Kinetics (Adult data unless noted)</span>\n    <p style=\"text-indent:0em;display:inline\">Absorption: Topical: Neonates: Detectable serum concentrations have been noted following topical chlorhexidine administration (Chapman 2013; Cowen 1979; Garland 2009)</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F51083813\" class=\"block fee drugH1Div\"><span class=\"drugH1\">Pricing: US</span>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Liquid</b> (Betasept Surgical Scrub External)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">4% (946 mL): $18.00</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Liquid</b> (Chlorhexidine Gluconate External)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">2% (118 mL): $4.38</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">4% (473 mL): $11.38</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Liquid</b> (Hibiclens External)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">4% (118 mL): $3.73</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Misc</b> (Tegaderm CHG Dressing External)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">(Dressing) (1): $10.01</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Solution</b> (Dyna-Hex 2 External)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">2% (473 mL): $5.04</p>\n    <p style=\"text-indent:0em;\">\n      <b>Disclaimer: </b>A representative AWP (Average Wholesale Price) price or price range is provided as reference price only. A range is provided when more than one manufacturer's AWP price is available and uses the low and high price reported by the manufacturers to determine the range. The pricing data should be used for benchmarking purposes only, and as such should not be used alone to set or adjudicate any prices for reimbursement or purchasing functions or considered to be an exact price for a single product and/or manufacturer.  Medi-Span expressly disclaims all warranties of any kind or nature, whether express or implied, and assumes no liability with respect to accuracy of price or price range data published in its solutions.  In no event shall Medi-Span be liable for special, indirect, incidental, or consequential damages arising from use of price or price range data.  Pricing data is updated monthly.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F50846846\" class=\"list fbnlist drugH1Div drugBrandNames\"><span class=\"drugH1\">Brand Names: International</span>\n    <ul>\n      <li>Acriflex (GB);</li>\n      <li>Alospray (PT);</li>\n      <li>Amident (RU);</li>\n      <li>Asseptic (BR);</li>\n      <li>Biorgasept (FR);</li>\n      <li>Cetavlex (FR);</li>\n      <li>Chlorhex (TH);</li>\n      <li>Chlorohex (SG);</li>\n      <li>Clorosan (IT);</li>\n      <li>Clorxil (ES);</li>\n      <li>Deb (AU);</li>\n      <li>Descutan (SE);</li>\n      <li>Dettol Sterilon (NL);</li>\n      <li>Diaseptyl (FR);</li>\n      <li>Dosiseptine (CH);</li>\n      <li>Eczmol/Cetraben Protect Antimicrobial Cream (MT);</li>\n      <li>Evoclens-4 (AU);</li>\n      <li>Handscrub (PT);</li>\n      <li>Hexicon (RU);</li>\n      <li>Hexiscrub (BD);</li>\n      <li>Hexisol (BD);</li>\n      <li>Hexitane (BD);</li>\n      <li>Hexoscrub (SG);</li>\n      <li>Hibidil (FR);</li>\n      <li>Hibiscrub (BE, CH, ES, FR, GB, IE, KW, LU, MT, NL, NO, QA, SA, SE, SG);</li>\n      <li>Hibitane (BE, DK, FR, IS, KW, MT, PT, QA, SA);</li>\n      <li>Hydrex (HK, IE, TH);</li>\n      <li>Klorhexol (FI);</li>\n      <li>Lifo-Scrub (GR);</li>\n      <li>LirahexidineTopical (EC);</li>\n      <li>Marclorhex (BR);</li>\n      <li>Mediscrub (ID);</li>\n      <li>Microshield (AU, HK, KR, SG);</li>\n      <li>Neoxene (IT);</li>\n      <li>Neoxinal (IT);</li>\n      <li>Normosept (ES);</li>\n      <li>Riotane Concentrate (AU);</li>\n      <li>Scanlin (HK);</li>\n      <li>Scrubing S 4% Soln (KR);</li>\n      <li>Septadine Scrub (IL);</li>\n      <li>Septal (IL);</li>\n      <li>Septalone (IL);</li>\n      <li>Sterets Unisept (IE);</li>\n      <li>Unisept (GB);</li>\n      <li>Vitawund (AT)</li></ul></div>\r\n</div><div id=\"topicAgreement\">Use of UpToDate is subject to the <a href=\"https://www.uptodate.com/legal/license\" class=\"licenseLink\" id=\"sla_in_page\">Subscription and License Agreement</a>.</div><div id=\"references\" class=\"headingAnchor\"><h1>REFERENCES</h1><ol id=\"reference\">\r\n<li>\r\n<div class=\"reference\">\n    American Academy of Pediatrics Committee on Drugs. &quot;Inactive&quot; ingredients in pharmaceutical products: update (subject review). <i>Pediatrics</i>. 1997;99(2):268-278.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/chlorhexidine-gluconate-topical-pediatric-drug-information/abstract-text/9024461/pubmed\" target=\"_blank\" id=\"9024461\">9024461</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Chapman AK, Aucott SW, Gilmore MM, Advani S, Clarke W, Milstone AM. Absorption and tolerability of aqueous chlorhexidine gluconate used for skin antisepsis prior to catheter insertion in preterm neonates. J Perinatol. 2013;33(10):768-771.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/chlorhexidine-gluconate-topical-pediatric-drug-information/abstract-text/23702618/pubmed\" target=\"_blank\" id=\"23702618\">23702618</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    ChloraPrep One-Step 10.6 mL (chlorhexidine) [prescribing information]. Leawood, KS: CareFusion; November 2013.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    ChloraPrep One-Step 3 mL (chlorhexidine) [prescribing information]. Leawood, KS: CareFusion; November 2013.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    de la Rosa M, Sturzenberger OP, Moore DJ. The use of chlorhexidine in the management of gingivitis in children. <i>J Periodontol</i>. 1988;59(6):387-389.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/chlorhexidine-gluconate-topical-pediatric-drug-information/abstract-text/3164781/pubmed\" target=\"_blank\" id=\"3164781\">3164781</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Garland JS, Alex CP, Mueller CD, Cisler-Kahill LA. Local reactions to a chlorhexidine gluconate-impregnated antimicrobial dressing in very low birth weight infants. <i>Pediatr Infect Dis J</i>. 1996;15(10):912-914.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/chlorhexidine-gluconate-topical-pediatric-drug-information/abstract-text/8895928/pubmed\" target=\"_blank\" id=\"8895928\">8895928</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Garland JS, Alex CP, Uhing MR, Peterside IE, Rentz A, Harris MC. Pilot trial to compare tolerance of chlorhexidine gluconate to povidone-iodine antisepsis for central venous catheter placement in neonates. <i>J Perinatol</i>. 2009;29(12):808-813.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/chlorhexidine-gluconate-topical-pediatric-drug-information/abstract-text/19812587/pubmed\" target=\"_blank\" id=\"19812587\">19812587</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Garland JS, Buck RK, Maloney P, et al. Comparison of 10% povidone-iodine and 0.5% chlorhexidine gluconate for the prevention of peripheral intravenous catheter colonization in neonates: a prospective trial. <i>Pediatr Infect Dis J</i>. 1995;14(6):510-516.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/chlorhexidine-gluconate-topical-pediatric-drug-information/abstract-text/7667056/pubmed\" target=\"_blank\" id=\"7667056\">7667056</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    O'Connor C, Philip RK, Powell J, et al. Combined education and skin antisepsis intervention for persistently high blood-culture contamination rates in neonatal intensive care. <i>J Hosp Infect</i>. 2016;93(1):105-107.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/chlorhexidine-gluconate-topical-pediatric-drug-information/abstract-text/26944902/pubmed\" target=\"_blank\" id=\"26944902\">26944902</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    O'Grady NP, Alexander M, Burns LA, et al. Guidelines for the prevention of intravascular catheter-related infections. <i>Clin Infect Dis</i>. 2011;52(9):e162-193.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/chlorhexidine-gluconate-topical-pediatric-drug-information/abstract-text/21460264/pubmed\" target=\"_blank\" id=\"21460264\">21460264</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    PerioGard (chlorhexidine gluconate) [prescribing information]. New York, NY: Colgate Oral Pharmaceuticals; July 2015.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Polin RA, Denson S, Brady MT, Committee on Fetus and Newborn, Committee on Infectious Diseases. Strategies for prevention of health care-associated infections in the NICU. <i>Pediatrics</i>. 2012;129(4):e1085-1093.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/chlorhexidine-gluconate-topical-pediatric-drug-information/abstract-text/22451712/pubmed\" target=\"_blank\" id=\"22451712\">22451712</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Shehab N, Lewis CL, Streetman DD, Donn SM. Exposure to the pharmaceutical excipients benzyl alcohol and propylene glycol among critically ill neonates. <i>Pediatr Crit Care Med</i>. 2009;10(2):256-259.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/chlorhexidine-gluconate-topical-pediatric-drug-information/abstract-text/19188870/pubmed\" target=\"_blank\" id=\"19188870\">19188870</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Tamma PD, Aucott SW, Milstone AM. Chlorhexidine use in the neonatal intensive care unit: results from a national survey. I<i>nfect Control Hosp Epidemiol</i>. 2010;31(8):846-849.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/chlorhexidine-gluconate-topical-pediatric-drug-information/abstract-text/20586654/pubmed\" target=\"_blank\" id=\"20586654\">20586654</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Yong D, Parker FC, and Foran SM, &ldquo;Severe Allergic Reactions and Intra-Urethral Chlorhexidine Gluconate,&rdquo; <i>Med J Aust</i>, 1995, 162(5):257-8.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/chlorhexidine-gluconate-topical-pediatric-drug-information/abstract-text/7891607/pubmed\" target=\"_blank\" id=\"7891607\">7891607</a>]</span></div>\r\n</li></ol></div><div id=\"topicVersionRevision\">Topic 115977 Version 6.0</div></div>","outline":"<div id=\"outlineSections\"><h2>Topic Outline</h2><ul><li class=\"plainItem\"><a sectionName=\"Brand Names: US\" href=\"#F50509982\" class=\"outlineLink\">Brand Names: US</a></li><li class=\"plainItem\"><a sectionName=\"Therapeutic Category\" href=\"#F50510537\" class=\"outlineLink\">Therapeutic Category</a></li><li class=\"plainItem\"><a sectionName=\"Dosing: Neonatal\" href=\"#F50713394\" class=\"outlineLink\">Dosing: Neonatal</a></li><li class=\"plainItem\"><a sectionName=\"Dosing: Usual\" href=\"#F50713395\" class=\"outlineLink\">Dosing: Usual</a></li><li class=\"plainItem\"><a sectionName=\"Dosage Forms\" href=\"#F50828729\" class=\"outlineLink\">Dosage Forms</a></li><li class=\"plainItem\"><a sectionName=\"Generic Availability (US)\" href=\"#F50509985\" class=\"outlineLink\">Generic Availability (US)</a></li><li class=\"plainItem\"><a sectionName=\"Administration\" href=\"#F50510540\" class=\"outlineLink\">Administration</a></li><li class=\"plainItem\"><a sectionName=\"Storage/Stability\" href=\"#F50510015\" class=\"outlineLink\">Storage/Stability</a></li><li class=\"plainItem\"><a sectionName=\"Use\" href=\"#F50510538\" class=\"outlineLink\">Use</a></li><li class=\"plainItem\"><a sectionName=\"Adverse Reactions\" href=\"#F50510005\" class=\"outlineLink\">Adverse Reactions</a></li><li class=\"plainItem\"><a sectionName=\"Contraindications\" href=\"#F50510000\" class=\"outlineLink\">Contraindications</a></li><li class=\"plainItem\"><a sectionName=\"Warnings/Precautions\" href=\"#F50510001\" class=\"outlineLink\">Warnings/Precautions</a></li><li class=\"plainItem\"><a sectionName=\"Warnings: Additional Pediatric Considerations\" href=\"#F50713392\" class=\"outlineLink\">Warnings: Additional Pediatric Considerations</a></li><li class=\"plainItem\"><a sectionName=\"Metabolism/Transport Effects\" href=\"#F50510010\" class=\"outlineLink\">Metabolism/Transport Effects</a></li><li class=\"plainItem\"><a sectionName=\"Drug Interactions\" href=\"#F50510007\" class=\"outlineLink\">Drug Interactions</a></li><li class=\"plainItem\"><a sectionName=\"Pregnancy Implications\" href=\"#F50509997\" class=\"outlineLink\">Pregnancy Implications</a></li><li class=\"plainItem\"><a sectionName=\"Monitoring Parameters\" href=\"#F50713396\" class=\"outlineLink\">Monitoring Parameters</a></li><li class=\"plainItem\"><a sectionName=\"Mechanism of Action\" href=\"#F50510016\" class=\"outlineLink\">Mechanism of Action</a></li><li class=\"plainItem\"><a sectionName=\"Pharmacodynamics/Kinetics (Adult data unless noted)\" href=\"#F50510017\" class=\"outlineLink\">Pharmacodynamics/Kinetics (Adult data unless noted)</a></li><li class=\"plainItem\"><a sectionName=\"Pricing: US\" href=\"#F51083813\" class=\"outlineLink\">Pricing: US</a></li><li class=\"plainItem\"><a sectionName=\"Brand Names: International\" href=\"#F50846846\" class=\"outlineLink\">Brand Names: International</a></li><li class=\"plainItem\"><a href=\"#references\">REFERENCES</a></li></ul></div><div><h2>GRAPHICS <a href=\"#\" id=\"viewAllGraphicsLink\">View All</a></h2><div id=\"outlineGraphics\"><ul><li><div id=\"DRUG_PED/115977|TAB\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"TABLES\">TABLES</a></div><ul><li><a href=\"image.htm?imageKey=DRUG/57469\" class=\"graphic graphic_table\">- Lexicomp clinical abbreviations</a></li></ul></li></ul></div></div><div><h2>RELATED TOPICS</h2><div id=\"outlineTopics\"><ul><li><a href=\"topic.htm?path=chlorhexidine-gluconate-topical-drug-information\" class=\"drug drug_general\">Chlorhexidine gluconate (topical): Drug information</a></li><li><a href=\"topic.htm?path=chlorhexidine-gluconate-topical-patient-drug-information\" class=\"drug drug_patient\">Chlorhexidine gluconate (topical): Patient drug information</a></li></ul></div></div>","javascript":null}